Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-03 · accession 0001437749-25-000466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-06 | 2025-01-03 | ETON | RIEDEL NORBERT G | Dir | M - OptEx | $3.65 | +102.4K | 137.1K | +295% | +$373.8K |
| DM | 2025-01-06 | 2025-01-03 | ETON | RIEDEL NORBERT G | Dir | M - OptEx | $0.00 | -102.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | M | A | 25,000 | $3.47 | 162,145 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-03 | M | A | 27,400 | $3.58 | 87,145 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-03 | M | A | 50,000 | $3.78 | 137,145 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-03 | M | D | 27,400 | $0.00 | 0 | D | $3.58 · 2021-03-12 to 2030-03-12 | 27,400 Common Stock | |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-03 | M | D | 50,000 | $0.00 | 0 | D | $3.78 · 2023-02-07 to 2032-02-06 | 50,000 Common Stock | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-03 | M | D | 25,000 | $0.00 | 0 | D | $3.47 · 2024-02-20 to 2033-02-19 | 25,000 Common Stock |